Email ID
Password
Scrip   
NICE gives a preliminary no to Avastin for bowel cancer
24 November 2009
Francesca Bruce

NICE, the health technology appraisal body for England and Wales, has given a preliminary no to funding Roche's Avastin (bevacizumab) for NHS patients with advanced bowel cancer. However, the firm says it hopes to change the institute's mind.
The institute today published an appraisal consultation...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36